Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Richard Katuramu"'
Autor:
Joan Rokani Bayowa, Joan N Kalyango, Joseph Baruch Baluku, Richard Katuramu, Emmanuel Ssendikwanawa, Jane Frances Zalwango, Rebecca Akunzirwe, Stella Maris Nanyonga, Judith Ssemasazi Amutuhaire, Ronald Kivumbi Muganga, Adolphus Cherop
Publikováno v:
PLOS Global Public Health, Vol 3, Iss 7, p e0001020 (2023)
Drug resistant tuberculosis (DR-TB)/HIV co-infection remains a growing threat to public health and threatens global TB and HIV prevention and care programs. HIV is likely to worsen the outcomes of DR-TB and DR-TB is likely to worsen the outcomes of H
Externí odkaz:
https://doaj.org/article/b6f40c6a0310439e9b6c57afdc9b7a8f
Autor:
Joseph Baruch Baluku, Richard Katuramu, Joshua Naloka, Enock Kizito, Martin Nabwana, Felix Bongomin
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Patients with drug resistant tuberculosis (DR-TB) with comorbidities and drug toxicities are difficult to treat. Guidelines recommend such patients to be managed in consultation with a multidisciplinary team of experts (the “TB
Externí odkaz:
https://doaj.org/article/7abe8f30c9a04ce1b61c1df73db75bf7
Publikováno v:
Implementation Science Communications, Vol 1, Iss 1, Pp 1-12 (2020)
Abstract Background Despite increasing access to antiretroviral therapy (ART), the proportion of eligible patients initiated on treatment remains suboptimal. Only 64.6% of the people living with HIV (PLHIV) globally were initiated on ART by June 2019
Externí odkaz:
https://doaj.org/article/f6766df1654d4b5c95b07bbda9265a7a
Autor:
Joseph Baruch Baluku, Bridget Nakazibwe, Joshua Naloka, Martin Nabwana, Sarah Mwanja, Rose Mulwana, Mike Sempiira, Sylvia Nassozi, Febronius Babirye, Carol Namugenyi, Samuel Ntambi, Sharon Namiiro, Felix Bongomin, Richard Katuramu, Irene Andia-Biraro, William Worodria
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 23, Iss , Pp 100221- (2021)
Background: Comorbid conditions and adverse drug events are associated with poor treatment outcomes among patients with drug resistant tuberculosis (DR – TB). This study aimed at determining the treatment outcomes of DR – TB patients with poor pr
Externí odkaz:
https://doaj.org/article/2a4b2f3e004f4b05b5fee67c594609cb
Autor:
Patricia Nahirya-Ntege, Adrian Cook, Tichaona Vhembo, Wilfred Opilo, Rachel Namuddu, Richard Katuramu, Jessica Tezikyabbiri, Bethany Naidoo-James, Diana Gibb, ARROW Trial Team
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e36186 (2012)
BACKGROUND:Provision of anti-retroviral therapy (ART) for HIV-infected children is complicated using syrup formulations, which are costlier than tablets, harder to transport and store and difficult for health-workers to prescribe and caregivers to ad
Externí odkaz:
https://doaj.org/article/e46d1a3e99d64dc9927c4feaaf2f89da
Autor:
Enock Kizito, Felix Bongomin, Richard Katuramu, Joseph Baruch Baluku, Joshua Naloka, Martin Nabwana
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Pulmonary Medicine
BMC Pulmonary Medicine
Background Patients with drug resistant tuberculosis (DR-TB) with comorbidities and drug toxicities are difficult to treat. Guidelines recommend such patients to be managed in consultation with a multidisciplinary team of experts (the “TB consilium
Autor:
Joseph Baruch Baluku, Bridget Nakazibwe, Amir Wasswa, Joshua Naloka, Samuel Ntambi, Damalie Waiswa, Mark Okwir, Martin Nabwana, Felix Bongomin, Richard Katuramu, Edwin Nuwagira, Kauthrah Ntabadde, Paul Katongole, Catherine Senyimba, Irene Andia-Biraro
Publikováno v:
Open forum infectious diseases. 9(10)
Background Although a third of people with tuberculosis (TB) are estimated to be coinfected with helminths, the prevalence is largely unknown among people with drug-resistant TB (DR-TB). We determined the prevalence of helminth coinfection among peop
Autor:
Bridget Nakazibwe, Sarah Mwanja, Carol Namugenyi, Febronius Babirye, Joshua Naloka, William Worodria, Mike Sempiira, Joseph Baruch Baluku, Rose Mulwana, Samuel Ntambi, Sylvia Nassozi, Sharon Namiiro, Richard Katuramu, Felix Bongomin, Irene Andia-Biraro, Martin Nabwana
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 23, Iss, Pp 100221-(2021)
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 23, Iss, Pp 100221-(2021)
Background: Comorbid conditions and adverse drug events are associated with poor treatment outcomes among patients with drug resistant tuberculosis (DR – TB). This study aimed at determining the treatment outcomes of DR – TB patients with poor pr
Autor:
Joseph Baruch Baluku, Rose Mulwana, Pallen Mugabe, Sylvia Nassozi, William Worodria, Richard Katuramu
Publikováno v:
BioMed Research International, Vol 2020 (2020)
BioMed Research International
BioMed Research International
Background. Rifampicin resistance (RR) is associated with mortality among tuberculosis (TB) patients coinfected with HIV. We compared the prevalence of RR among TB patients with and without HIV coinfection at the National Tuberculosis Treatment Cente
Publikováno v:
Implementation Science Communications
Implementation Science Communications, Vol 1, Iss 1, Pp 1-12 (2020)
Implementation Science Communications, Vol 1, Iss 1, Pp 1-12 (2020)
Background Despite increasing access to antiretroviral therapy (ART), the proportion of eligible patients initiated on treatment remains suboptimal. Only 64.6% of the people living with HIV (PLHIV) globally were initiated on ART by June 2019. The str